Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma ; volume:10 ; number:1 ; day:20 ; month:5 ; year:2010 ; pages:1-6 ; date:12.2010
BMC cancer ; 10, Heft 1 (20.5.2010), 1-6, 12.2010
- Urheber
-
Zhao, Po
- Beteiligte Personen und Organisationen
-
Li, Yazhuo
Lu, Yali
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-218
- URN
-
urn:nbn:de:1111-2016030358111
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhao, Po
- Li, Yazhuo
- Lu, Yali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aberrant ADAM10 expression correlates with osteosarcoma progression
CD133 antigen expression in ovarian cancer
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis
Increased PHGDH expression promotes aberrant melanin accumulation
Aberrant ADAM10 expression correlates with osteosarcoma progression
CD133 antigen expression in ovarian cancer
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis
Increased PHGDH expression promotes aberrant melanin accumulation
Aberrant ADAM10 expression correlates with osteosarcoma progression
CD133 antigen expression in ovarian cancer
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
CD133-regulated nucleophosmin expression in human colon cancer cells
Prognostic impact of CD133 expression in Endometrial Cancer Patients
Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis